Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
Described herein are compositions and methods of use of anti-Trop-2 antibodies or antigen-binding fragment thereof to isolate, enrich, detect, diagnose and/or characterize circulating tumor cells (CTCs) from patients with a Trop-2 positive cancer. Preferably, the antibody is an RS7, 162-46.2 or MAB650 antibody. The compositions and methods are of use to detect, diagnose and/or treat metastatic Trop-2+ cancers, such as breast, ovarian, cervical, endometrial, lung, prostate, colon, rectum, stomach, esophageal, bladder, renal, pancreatic, thyroid, epithelial or head-and-neck cancer.
Immunomedics, Inc.
A G A G A G G A A G A A G A
A61K G01N A61K G01N A61P G01N G01N A61P A61K G01N A61K A61K G01N A61K
inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional additional inventional
David M. Hans J. Chien-Hsing
Goldenberg Hansen Chang